Our current research projects lead to a better understanding of how rare disorders occur, improving the diagnosis of those conditions, and identifying effective and personalized interventions to prevent and treat symptoms.
At the Greenwood Genetic Center, we utilize cutting-edge technologies along with cell- and animal-based model systems to unravel the complex causes of genetic diseases.
These tools include powerful instrumentation for imaging, metabolic profiling, cell biology, and biochemistry, along with a model organism – the zebrafish.
GGC’s Research Division brings broad expertise in a wide range of rare diseases. Our team conducts foundational research on congenital disorders of glycosylation, lysosomal storage disorders, and inherited retinal diseases, advancing knowledge that leads to improved diagnosis and treatment. In addition, our functional studies program takes this work further by using cell- and animal-based models to better understand variants of uncertain significance identified through genetic testing.
While no longer an active area of study at GGC, the archived XLID resources below are provided to continue to support clinicians in their diagnosis and treatment of patients with XLID.
Last updated: February 2025
Interested in learning how these research projects could impact you or someone you love? Our team is available to answer any questions and provide any additional information you may need.